Page last updated: 2024-11-08

pentylenetetrazole and Peripheral Nerve Diseases

pentylenetetrazole has been researched along with Peripheral Nerve Diseases in 1 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petrillo, P1
Angelici, O1
Bingham, S1
Ficalora, G1
Garnier, M1
Zaratin, PF1
Petrone, G1
Pozzi, O1
Sbacchi, M1
Stean, TO1
Upton, N1
Dondio, GM1
Scheideler, MA1

Other Studies

1 other study available for pentylenetetrazole and Peripheral Nerve Diseases

ArticleYear
Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-23586
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:3

    Topics: Animals; Binding, Competitive; Carrageenan; Cells, Cultured; Convulsants; Cyclic AMP; Electroshock;

2003